Nuvation Bio Inc.
NUVB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 10.1% | – | – | – |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | -7,200.7% | – | – | – |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -7,213.8% | – | – | – |
| EPS Diluted | -2.11 | -0.35 | -0.48 | -0.44 |
| % Growth | -502.9% | 27.1% | -9.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |